Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 565 to 571 of 571 entries
Sorted by: Best Match Show Resources per page
Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing.

Injury

Chiang E, Case J, Cook MR, Schreiber M, Sorenson C, Barton C.
PMID: 34802698
Injury. 2021 Nov 01; doi: 10.1016/j.injury.2021.10.021. Epub 2021 Nov 01.

BACKGROUND: Methamphetamine (M) is a widely used, powerful sympathomimetic drug that produces significant CNS stimulation. Its use is associated with psychiatric disorders, abnormal brain chemistry, and cardiovascular disease. Pre-hospital M use is associated with increased intubation, intensive care unit...

Cite
Chiang E, Case J, Cook MR, et al. Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing. Injury. 2021;doi: 10.1016/j.injury.2021.10.021.
Chiang, E., Case, J., Cook, M. R., Schreiber, M., Sorenson, C., & Barton, C. (2021). Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing. Injury, . https://doi.org/10.1016/j.injury.2021.10.021
Chiang, Elaine, et al. "Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing." Injury vol. (2021). doi: https://doi.org/10.1016/j.injury.2021.10.021
Chiang E, Case J, Cook MR, Schreiber M, Sorenson C, Barton C. Sedation and analgesia needs in methamphetamine intoxicated patients: much ado about nothing. Injury. 2021 Nov 01; doi: 10.1016/j.injury.2021.10.021. Epub 2021 Nov 01. PMID: 34802698.
Copy Download .nbib Format: NLM
Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Bateman TM, Heller GV, Beanlands R, Calnon DA, Case J, deKemp R, DePuey EG, Di Carli M, Guler EC, Murthy VL, Rosenblatt J, Sher R, Slomka P, Ruddy TD.
PMID: 33789935
J Nucl Med. 2021 Nov;62(11):1599-1615. doi: 10.2967/jnumed.121.261989. Epub 2021 Mar 31.

No abstract available.

Cite
Bateman TM, Heller GV, Beanlands R, et al. Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2021;62(11):1599-1615doi: 10.2967/jnumed.121.261989.
Bateman, T. M., Heller, G. V., Beanlands, R., Calnon, D. A., Case, J., deKemp, R., DePuey, E. G., Di Carli, M., Guler, E. C., Murthy, V. L., Rosenblatt, J., Sher, R., Slomka, P., & Ruddy, T. D. (2021). Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 62(11), 1599-1615. https://doi.org/10.2967/jnumed.121.261989
Bateman, Timothy M, et al. "Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging." Journal of nuclear medicine : official publication, Society of Nuclear Medicine vol. 62,11 (2021): 1599-1615. doi: https://doi.org/10.2967/jnumed.121.261989
Bateman TM, Heller GV, Beanlands R, Calnon DA, Case J, deKemp R, DePuey EG, Di Carli M, Guler EC, Murthy VL, Rosenblatt J, Sher R, Slomka P, Ruddy TD. Practical Guide for Interpreting and Reporting Cardiac PET Measurements of Myocardial Blood Flow: An Information Statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging. J Nucl Med. 2021 Nov;62(11):1599-1615. doi: 10.2967/jnumed.121.261989. Epub 2021 Mar 31. PMID: 33789935; PMCID: PMC8612323.
Copy Download .nbib Format: NLM
The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications.

Clinical pharmacology and therapeutics

Purpura CA, Garry EM, Honig N, Case A, Rassen JA.
PMID: 34726771
Clin Pharmacol Ther. 2022 Jan;111(1):135-144. doi: 10.1002/cpt.2474. Epub 2021 Nov 22.

The US Food and Drug Administration (FDA) is open to accepting real-world evidence (RWE) to support its assessment of medical products. However, RWE stakeholders lack a shared understanding of FDA's evidentiary expectations for the use of RWE in applications...

Cite
Purpura CA, Garry EM, Honig N, et al. The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications. Clin Pharmacol Ther. 2021;111(1):135-144doi: 10.1002/cpt.2474.
Purpura, C. A., Garry, E. M., Honig, N., Case, A., & Rassen, J. A. (2022). The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications. Clinical pharmacology and therapeutics, 111(1), 135-144. https://doi.org/10.1002/cpt.2474
Purpura, Christina A, et al. "The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications." Clinical pharmacology and therapeutics vol. 111,1 (2022): 135-144. doi: https://doi.org/10.1002/cpt.2474
Purpura CA, Garry EM, Honig N, Case A, Rassen JA. The Role of Real-World Evidence in FDA-Approved New Drug and Biologics License Applications. Clin Pharmacol Ther. 2022 Jan;111(1):135-144. doi: 10.1002/cpt.2474. Epub 2021 Nov 22. PMID: 34726771.
Copy Download .nbib Format: NLM
Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging.

Cureus

Threadcraft MA, Case R.
PMID: 33754108
Cureus. 2021 Feb 16;13(2):e13385. doi: 10.7759/cureus.13385.

Electronic (E)-cigarette use or vaping is associated with pulmonary injury. Users can present with wide-ranging symptoms, varying degrees of pulmonary injury, and respiratory distress. Lung injury secondary to vaping is associated with a variety of patterns on pulmonary imaging....

Cite
Threadcraft MA, Case R. Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging. Cureus. 2021;13(2):e13385doi: 10.7759/cureus.13385.
Threadcraft, M. A., & Case, R. (2021). Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging. Cureus, 13(2), e13385. https://doi.org/10.7759/cureus.13385
Threadcraft, Marcus A, and Case, Robert. "Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging." Cureus vol. 13,2 (2021): e13385. doi: https://doi.org/10.7759/cureus.13385
Threadcraft MA, Case R. Vape-Associated Pulmonary Injury (VAPI) Presenting With a "Miliary" Pattern on Imaging. Cureus. 2021 Feb 16;13(2):e13385. doi: 10.7759/cureus.13385. PMID: 33754108; PMCID: PMC7971726.
Copy Download .nbib Format: NLM
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants.

Cell host & microbe

Liu C, Zhou D, Nutalai R, Duyvesteyn HME, Tuekprakhon A, Ginn HM, Dejnirattisai W, Supasa P, Mentzer AJ, Wang B, Case JB, Zhao Y, Skelly DT, Chen RE, Johnson SA, Ritter TG, Mason C, Malik T, Temperton N, Paterson NG, Williams MA, Hall DR, Clare DK, Howe A, Goulder PJR, Fry EE, Diamond MS, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR.
PMID: 34921776
Cell Host Microbe. 2022 Jan 12;30(1):53-68.e12. doi: 10.1016/j.chom.2021.11.013. Epub 2021 Nov 27.

Alpha-B.1.1.7, Beta-B.1.351, Gamma-P.1, and Delta-B.1.617.2 variants of SARS-CoV-2 express multiple mutations in the spike protein (S). These may alter the antigenic structure of S, causing escape from natural or vaccine-induced immunity. Beta is particularly difficult to neutralize using serum...

Cite
Liu C, Zhou D, Nutalai R, et al. The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants. Cell Host Microbe. 2021;30(1):53-68.e12doi: 10.1016/j.chom.2021.11.013.
Liu, C., Zhou, D., Nutalai, R., Duyvesteyn, H. M. E., Tuekprakhon, A., Ginn, H. M., Dejnirattisai, W., Supasa, P., Mentzer, A. J., Wang, B., Case, J. B., Zhao, Y., Skelly, D. T., Chen, R. E., Johnson, S. A., Ritter, T. G., Mason, C., Malik, T., Temperton, N., Paterson, N. G., Williams, M. A., Hall, D. R., Clare, D. K., Howe, A., Goulder, P. J. R., Fry, E. E., Diamond, M. S., Mongkolsapaya, J., Ren, J., Stuart, D. I., & Screaton, G. R. (2022). The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants. Cell host & microbe, 30(1), 53-68.e12. https://doi.org/10.1016/j.chom.2021.11.013
Liu, Chang, et al. "The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants." Cell host & microbe vol. 30,1 (2022): 53-68.e12. doi: https://doi.org/10.1016/j.chom.2021.11.013
Liu C, Zhou D, Nutalai R, Duyvesteyn HME, Tuekprakhon A, Ginn HM, Dejnirattisai W, Supasa P, Mentzer AJ, Wang B, Case JB, Zhao Y, Skelly DT, Chen RE, Johnson SA, Ritter TG, Mason C, Malik T, Temperton N, Paterson NG, Williams MA, Hall DR, Clare DK, Howe A, Goulder PJR, Fry EE, Diamond MS, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR. The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants. Cell Host Microbe. 2022 Jan 12;30(1):53-68.e12. doi: 10.1016/j.chom.2021.11.013. Epub 2021 Nov 27. PMID: 34921776; PMCID: PMC8626228.
Copy Download .nbib Format: NLM
UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center.

Transplantation direct

Kurian SM, Spierling Bagsic SR, Case J, Barrick BL, Schaffer R, Rice JC, Marsh CL.
PMID: 34386576
Transplant Direct. 2021 Aug 05;7(9):e738. doi: 10.1097/TXD.0000000000001196. eCollection 2021 Sep.

BACKGROUND: Focal segmental glomerulosclerosis (FSGS) is a common recurrent glomerulopathy associated with graft loss and patient survival after kidney transplantation (KT). However, its natural history, clinical predictors, and treatment response are still poorly understood. Steroid withdrawal regimens in KT...

Cite
Kurian SM, Spierling Bagsic SR, Case J, et al. UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center. Transplant Direct. 2021;7(9):e738doi: 10.1097/TXD.0000000000001196.
Kurian, S. M., Spierling Bagsic, S. R., Case, J., Barrick, B. L., Schaffer, R., Rice, J. C., & Marsh, C. L. (2021). UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center. Transplantation direct, 7(9), e738. https://doi.org/10.1097/TXD.0000000000001196
Kurian, Sunil M, et al. "UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center." Transplantation direct vol. 7,9 (2021): e738. doi: https://doi.org/10.1097/TXD.0000000000001196
Kurian SM, Spierling Bagsic SR, Case J, Barrick BL, Schaffer R, Rice JC, Marsh CL. UNOS/OPTN Data-guided Assessment of Focal Segmental Glomerulosclerosis After Kidney Transplantation and Evaluation of Immunosuppressive Protocols in a Steroid-free Center. Transplant Direct. 2021 Aug 05;7(9):e738. doi: 10.1097/TXD.0000000000001196. eCollection 2021 Sep. PMID: 34386576; PMCID: PMC8354624.
Copy Download .nbib Format: NLM
Medical Schools' Willingness to Accommodate Medical Students with Sensory and Physical Disabilities: Ethical Foundations of a Functional Challenge to "Organic" Technical Standards.

McKee M, Case B, Fausone M, Zazove P, Ouellette A, Fetters MD.
UIID-AD: 4247
2016;993-1002. doi: 10.1001/journalofethics.2016.18.10.medu1-1610.

Students with sensory and physical disabilities are underrepresented in medical schools despite the availability of assistive technologies and accommodations. Unfortunately, many medical schools have adopted restrictive "organic" technical standards based on deficits rather than on the ability to do...

Cite
McKee M, Case B, Fausone M, et al. Medical Schools' Willingness to Accommodate Medical Students with Sensory and Physical Disabilities: Ethical Foundations of a Functional Challenge to "Organic" Technical Standards. 2016;993-1002doi: 10.1001/journalofethics.2016.18.10.medu1-1610.
McKee, M., Case, B., Fausone, M., Zazove, P., Ouellette, A., & Fetters, M. D. (2016). Medical Schools' Willingness to Accommodate Medical Students with Sensory and Physical Disabilities: Ethical Foundations of a Functional Challenge to "Organic" Technical Standards. 993-1002. https://doi.org/10.1001/journalofethics.2016.18.10.medu1-1610
McKee, M, et al. "Medical Schools' Willingness to Accommodate Medical Students with Sensory and Physical Disabilities: Ethical Foundations of a Functional Challenge to "Organic" Technical Standards." vol. (2016): 993-1002. doi: https://doi.org/10.1001/journalofethics.2016.18.10.medu1-1610
McKee M, Case B, Fausone M, Zazove P, Ouellette A, Fetters MD. Medical Schools' Willingness to Accommodate Medical Students with Sensory and Physical Disabilities: Ethical Foundations of a Functional Challenge to "Organic" Technical Standards. 2016;993-1002. doi: 10.1001/journalofethics.2016.18.10.medu1-1610. UIID-AD: 4247.
Copy Download .nbib Format: NLM
Showing 565 to 571 of 571 entries